stockrowTenon Medical, Inc.
TNON Healthcare Medical Devices
Tenon Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 million, up 20.4% from fiscal 2024.
- Revenue
- +126.8%
- EPS
- +1.88%
- Free cash flow
- −21.8%
Quarter to June 2026, against a year earlier
Follow TNON
Alert me
Tenon Medical, Inc. (TNON) EV/Sales
As of 6 November 2026, Tenon Medical, Inc. (TNON) trades at a EV/Sales of −0.2×. Over the past ten years it has ranged from −14.2× (September 2022) to 238× (May 2022); the current reading is higher than 32% of that period. That is below the Medical Devices industry median of 2.8× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.9× | — |
| FY2024 | −1.2× | — |
| FY2023 | 0.2× | (96.33%) |
| FY2022 | 6.8× | (92.99%) |
| FY2021 | 96.6× | 0.00% |
| FY2020 | 96.6× | 0.00% |
| FY2019 | 96.6× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.5× | (46.87%) |
| Mar 2026 | 0.9× | (7.02%) |
| Dec 2025 | 0.9× | (55.41%) |
| Sep 2025 | 2.1× | — |
| 18 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| NVNO enVVeno Medical Corporation compare | −50.8× |
| TNON Tenon Medical, Inc. | −0.2× |
| WOK WORK Medical Technology Group LTD compare | n/m |
| BDMD Baird Medical Investment Holdings Limited compare | n/m |
| TBIO Telesis Bio Inc. compare | 0.1× |
| VVOS Vivos Therapeutics, Inc. compare | 0.4× |
| XAIR Beyond Air, Inc. compare | 1.1× |
| TRIB Trinity Biotech PLC compare | 3.0× |
| VNRX VolitionRX Limited compare | 4.1× |
| Medical Devices industry median | 2.8× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)